课题基金 / 基金详情

The role of presenilin in the formation of neurofibrillary tangles via GSK-3β

The role of presenilin in the formation of neurofibrillary tangles via GSK-3β
早老素通过 GSK-3β 在神经原纤维缠结形成中的作用
批准号:
15590879
负责人:
IKEDA Masaki
金额:
$1.92万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004

项目摘要

项目成果

IKEDA Masaki的其他基金

相似基金

相关文献

中文摘要
翻译
本研究通过构建GSK-3β cDNA连接小鼠Thy-1启动子的转基因小鼠,探讨GSK-3β与tau蛋白的相互作用。我们检测了3、6、12月龄转基因小鼠脑切片的免疫细胞化学。糖原合成酶激酶-3 β(Glycogen synthase kinase-3 β,GSK-3β)在tau蛋白磷酸化过程中起重要作用。这一证据被认为是诱导形成在包括阿尔茨海默病在内的tau蛋白病中观察到的神经元缠结(NFT)。阐明GSK-3β参与NFT和神经元细胞死亡的机制,对于开发新的治疗方法具有重要意义。目的:观察GSK-3β转基因小鼠细胞形态结构的免疫细胞化学变化。观察3只GSK-3β转基因小鼠3、8、12月龄脑和脊髓的免疫细胞化学研究。我们对过表达组成型活性GSK-3β(S9 A)的转基因小鼠进行了免疫细胞化学研究,结果表明,GSK-3β在3 ~ 12月龄的小鼠神经细胞胞浆和树突中的表达呈年龄依赖性增加。脑和脊髓中微管相关蛋白2(MAP 2)水平的降低以及神经元树突中神经丝的SMI-31、NF-200免疫反应性的降低。这些结果提示GSK-3β在体内过表达可导致神经细胞内磷酸化神经丝和MAP 2蛋白减少,导致细胞骨架结构异常改变和神经功能障碍。
英文摘要
We generated the transgenic mice overexpressing GSK-3β cDNA ligating mouse Thy-1 promoter, in order to elucidate the relationship of the interaction GSK-3β and tau accumulation. We examined the immunocytochemistry of the brains slides of 3,6,12-month-old transgenic mice. Glycogen synthase kinase-3β(GSK-3β) plays an important role in phosphorylation of tau. This evidence is thought to be induced to form neurofibrillary tangles(NFT) observed in tauopathies including Alzheimer's disease. It is crucial to elucidate the mechanism of GSK-3β involved in NFT and neuronal cell death, to develop novel therapy for these diseases. To elucidate immunocytochemical changes of cytoskeltal structures in GSK-3β transgenic mice. To examine immunocytochemical study of three GSK-3β transgenic mice brains and spinal cords at 3,8 and 12 months. We examined immunocytochemical study of transgenic mice overexpressing a constitutively active GSK-3β(S9A), and demonstrate that the expression of GSK-3β increased in the cytoplasm and dendrites of neuronal cells in age dependent manner at 3 to 12 months. The reduction of the level of the microtubule-associated protein 2(MAP2) in brain and in spinal cord, and immunoreactivity of neurofilament by antibodies SMI-31,NF-200 slightly decreased in the dendrites of neurons. These findings suggested that overexpression of GSK-3β in vivo led to decrease of phophorylated neurofilaments and MAP2 protein in neuronal cells, leading to aberrant change of cytoskeltal structures and neuronal dysfuction.
期刊论文(11)
专著(0)
科研奖励(0)
会议论文
Matsubara E, Sekijima Y, Ikeda M: "Soluble Aβ homeostasis in AD and DS"Neurobiology of Aging. (印刷中). (2004)
Matsubara E、Sekijima Y、Ikeda M:“AD 和 DS 中的可溶性 Aβ 稳态”《衰老神经生物学》(出版中)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Ikarashi Y, Harigaya Y, Ikeda M: "Decreased level of brain acetylcholine and memory disturbance in APPsw mice."Neurobiology of Aging. 25・4. 483-90 (2004)
Ikarashi Y、Harigaya Y、Ikeda M:“APPsw 小鼠脑乙酰胆碱水平降低和记忆障碍。”衰老神经生物学 25・4(2004)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Soluble Abeta homeostasis in AD and DS : impairment of anti-amyloidogenic protection by lipoproteins
AD 和 DS 中的可溶性 Abeta 稳态:脂蛋白的抗淀粉样蛋白形成保护受损
DOI: --
发表时间: 2004
期刊: Neurobiology of Aging 25・7
影响因子: --
作者: [Matsubara E, Sekijima Y, Ikeda M, Shoji M]
通讯作者: Shoji M
Soluble Aβ homeostasis in AD and DS
AD 和 DS 中可溶性 Aβ 稳态
DOI: --
发表时间: 2004
期刊: Neurobiology of Aging 25
影响因子: --
作者: [Matsubara E, Sekijima Y, Ikeda M]
通讯作者: Ikeda M
共 6 条
    Analysis of synaptic disorder and GSK-3β in formation of neurofibrillary tangles
    • 批准号:
      19590980
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2007
    • 负责人:
      IKEDA Masaki
    • 依托单位:
    Analysis of functional roles of presenilin and GSK-3β in molecular mechanism of neurofibrillary tangles
    • 批准号:
      17590860
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.24万
    • 财政年份:
      2005
    • 负责人:
      IKEDA Masaki
    • 依托单位:
    国内基金
    海外基金
    泛素连接酶Hrd1介导的tau蛋白降解
    • 批准号:
      30772557
    • 项目类别:
      面上项目
    • 资助金额:
      34.0万元
    • 批准年份:
      2007
    • 负责人:
      沈玉先
    • 依托单位: